Kenneth A Krohn Selected Research

alovudine

5/2015	In vitro analysis of transport and metabolism of 4'-thiothymidine in human tumor cells.
11/2012	Levels of human equilibrative nucleoside transporter-1 are higher in proliferating regions of A549 tumor cells grown as tumor xenografts in vivo.
10/2012	The effects of 5-fluoruracil treatment on 3'-fluoro-3'-deoxythymidine (FLT) transport and metabolism in proliferating and non-proliferating cultures of human tumor cells.
9/2009	NCI-sponsored trial for the evaluation of safety and preliminary efficacy of 3'-deoxy-3'-[18F]fluorothymidine (FLT) as a marker of proliferation in patients with recurrent gliomas: preliminary efficacy studies.
10/2006	Kinetic analysis of 3'-deoxy-3'-18F-fluorothymidine in patients with gliomas.
2/2005	Kinetic analysis of 3'-deoxy-3'-fluorothymidine PET studies: validation studies in patients with lung cancer.
2/2005	Kinetic modeling of 3'-deoxy-3'-fluorothymidine in somatic tumors: mathematical studies.
5/2004	Effect of p53 activation on cell growth, thymidine kinase-1 activity, and 3'-deoxy-3'fluorothymidine uptake.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenneth A Krohn Research Topics

Disease

44	Neoplasms (Cancer) 01/2021 - 04/2002
19	Hypoxia (Hypoxemia) 05/2022 - 04/2004
11	Breast Neoplasms (Breast Cancer) 01/2021 - 04/2004
8	Glioblastoma (Glioblastoma Multiforme) 05/2022 - 12/2002
8	Glioma (Gliomas) 01/2020 - 04/2002
5	Brain Neoplasms (Brain Tumor) 01/2020 - 07/2002
3	Disease Progression 10/2016 - 10/2006
3	Head and Neck Neoplasms (Head and Neck Cancer) 06/2008 - 04/2004
2	Sarcoma (Soft Tissue Sarcoma) 04/2011 - 04/2004
1	Pathologic Processes 01/2018
1	Carcinogenesis 06/2008
1	Pheochromocytoma 02/2006
1	Lung Neoplasms (Lung Cancer) 02/2005
1	Hematologic Neoplasms (Hematological Malignancy) 01/2005

Drug/Important Bio-Agent (IBA)

15	fluoromisonidazoleIBA 05/2022 - 04/2004
9	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021 - 12/2002
9	Estrogen ReceptorsIBA 01/2021 - 06/2006
8	alovudineIBA 05/2015 - 05/2004
7	ThymidineIBA 05/2015 - 07/2002
7	Biological ProductsIBA 03/2015 - 01/2005
6	Aromatase InhibitorsIBA 01/2021 - 06/2006
5	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 04/2002
4	Oxygen (Dioxygen)IBA 01/2018 - 05/2004
4	Estrogens (Estrogen)FDA Link 01/2017 - 06/2008
4	Biomarkers (Surrogate Marker)IBA 01/2017 - 11/2005
4	NucleosidesIBA 11/2012 - 12/2003
4	DNA (Deoxyribonucleic Acid)IBA 01/2005 - 07/2002
3	Tamoxifen FDA LinkGeneric 07/2011 - 06/2006
3	EnzymesIBA 09/2010 - 12/2003
2	Fulvestrant (Faslodex)FDA Link 01/2017 - 07/2011
2	Cytotoxins (Cytolysins)IBA 03/2015 - 01/2005
2	thiamine triphosphorate (TTP)IBA 05/2008 - 12/2002
2	copper (II) diacetyl- di(N(4)- methylthiosemicarbazone)IBA 04/2007 - 01/2005
2	Pharmaceutical PreparationsIBA 10/2006 - 11/2005
2	antibiotic K 4 (K 4)IBA 02/2005 - 02/2005
1	pembrolizumabIBA 05/2022
1	Vorinostat FDA Link 01/2021
1	Histone Deacetylase InhibitorsIBA 01/2021
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2021
1	human ERBB2 proteinIBA 01/2021
1	Bevacizumab (Avastin)FDA Link 10/2016
1	4'-thiothymidineIBA 05/2015
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 04/2011
1	thymidine kinase 1IBA 09/2010
1	GadoliniumIBA 01/2009
1	Radioisotopes (Radionuclides)IBA 06/2008
1	Lactic Acid (Lactate)FDA LinkGeneric 06/2008
1	Transcription Factors (Transcription Factor)IBA 05/2008
1	RadiopharmaceuticalsIBA 06/2007
1	Hypoxia-Inducible Factor 1IBA 10/2006
1	IsoenzymesIBA 10/2006
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 10/2006
1	3-Iodobenzylguanidine (Iobenguane)IBA 02/2006
1	NucleotidesIBA 02/2005
1	Cytostatic AgentsIBA 01/2005
1	Deoxyglucose (2 Deoxy D glucose)IBA 04/2002

Therapy/Procedure

24	Therapeutics 01/2021 - 07/2002
8	Radiotherapy 01/2020 - 04/2002
2	Drug Therapy (Chemotherapy) 01/2020 - 05/2008
1	Immunotherapy 05/2022
1	Chemoradiotherapy 01/2020
1	Precision Medicine 10/2016
1	Electrodes (Electrode) 06/2008
1	Conformal Radiotherapy 04/2007
1	Adrenalectomy 02/2006
1	Radioimmunotherapy 01/2005
1	Cell Transplantation 01/2005
1	Aftercare (After-Treatment) 07/2002